1-3 of 3
Sheilagh Barclay
Close
Sort by
Journal Articles

Dose and Time-Dependent Association of Red Blood Cell Transfusion with Increased Risk of GvHD and Worse Survival after Allogeneic HSCT

Sakura Hosoba, MD, Edmund K. Waller, MD PhD, Sheilagh Barclay, MT(ASCP), Kirk A Easley, MS, Neeta Shenvi, MS, John Roback, MD PhD, James C. Zimring, MD PhD, Cynthia R. Giver, PhD
Journal: Blood
Blood (2014) 124 (21): 1555.
https://doi.org/10.1182/blood.V124.21.1555.1555
Published: 2014
Journal Articles

Allogeneic HSCT Patients Receiving More RBC Transfusions Are At Increased Risk For Development Of Grade 2-4 Acute Graft-Versus-Host Disease

Cynthia R. Giver, PhD, Zahir Ali, Sheilagh Barclay, Sakura Hosaba, MD, Qunna Li, John Roback, MD, PhD, Edmund K. Waller, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3298.
https://doi.org/10.1182/blood.V122.21.3298.3298
Published: 2013
Journal Articles

High-Throughput Amplification and Detection of Human Erythrocyte Antigen (HEA) Nucleotide Polymorphisms From Leukocyte Reduced Red Blood Cell (RBC) Units: Implications for Minor RBC Antigen Inventory Management by Hospital Transfusion Services

Cassandra Josephson, MD, John Roback, MD, PhD, Robert Myers, MT(ASCP), Lisa Hallock, MT(ASCP), Irene DeMezzo, MT(ASCP), Christopher Tanzi, MBA, Adelbert James, PhD, MPH, Courtney K Hopkins, DO, Sheilagh Barclay, MT(ASCP), Ermelina Enriquez, BS, X. Lin, PhD, Ghazala Hashmi, PhD
Journal: Blood
Blood (2010) 116 (21): 3348.
https://doi.org/10.1182/blood.V116.21.3348.3348
Published: 2010